Vincerx Pharma (VINC)
(Delayed Data from NSDQ)
$0.78 USD
0.00 (-0.12%)
Updated Sep 4, 2024 03:58 PM ET
After-Market: $0.78 0.00 (0.12%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Vincerx Pharma (VINC) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 70.59%. Look out for VINC's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 63.04%.
Earnings History
Price & Consensus
Zacks News for VINC
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
VINC: What are Zacks experts saying now?
Zacks Private Portfolio Services